PGY-2 Medication-Use Safety & Policy Residency

Purpose

PGY2 residency programs build upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if available.

Additional Program Description

The Postgraduate Year Two (PGY2) Medication-Use Safety and Policy (MUSP) is designed to develop accountability; practice patterns; habits; and expert knowledge, skills, attitudes, and abilities in the respective advanced area of pharmacy practice. This program builds upon the broad-based competencies achieved in a PGY1 residency, deepening the resident's ability to provide care in the most complex of cases or in the support of care through practice leadership. The PGY1 program provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and transforming both into improved medication therapy for patients.

This specialty residency is designed to develop practitioners who possess an expert level of competency in drug information practice, formulary management, medication safety, and policies/procedures. The program allows sufficient flexibility to adapt to the individual needs of the resident, while ensuring that all ASHP standards for drug information specialized residency training are met. 

Upon completion of this program, the resident will be prepared to enter a variety of positions related to MSUP practice. A resident who successfully completes an accredited PGY2 MSUP Residency should possess the skills needed to excel in the following positions: clinical specialist in Drug Information, Drug Information faculty member, coordinator/manager of Drug Information Services, medical writer/editor, formulary manager/specialist, or medication safety pharmacist. Additionally, upon completion of the PGY2 program, the resident should possess competencies that enable attainment of board certification (ie, BCPS).

Program Design

Required Learning Experiences

  • Orientation – 1 month
  • Drug Information – 11 months (longitudinal)
  • Medication Safety, Use & Policy I – 2 to 4 weeks (longitudinal or additional experiences depending on availability/need/interest)
  • Medication Safety, Use & Policy II – 2 to 4 weeks (longitudinal or additional experiences depending on availability/need/interest)
  • Formulary Management (P&T) – 6 to 9 months
  • Drug Information Academia – 1 semester (fall)
  • Informatics – 4 to 8 weeks (or longitudinal)
  • Drug Information Student Precepting – 2 months
  • Drug Shortages – 2-4 weeks (or longitudinal)
  • Service project and manuscript – Longitudinal
  • Medication-use evaluation – Longitudinal (coordination of mini-MUEs based on need)
  • Seminar – 1 presentation
  • Operational staffing – Approximately 16 hours every 3 to 4 weeks 

Core Preceptors

Jason C. Cooper, PharmD
Clinical Specialist, Medication Safety, Use & Policy
cooperjc@musc.edu

Jimmy New, PharmD, BCPS
Clinical Specialist, Medication Safety, Use & Policy
new@musc.edu  

Hannah Vining, PharmD, MBA, BCPS
Clinical Specialist, Medication Safety, Use & Policy
viningh@musc.edu

Chris Wisniewski, PharmD, MSCR, BCPS
Clinical Specialist, Medication Safety, Use & Policy Professor, MUSC College of Pharmacy
wisniews@musc.edu

Kathryn Noyes, PharmD, BCPS
Clinical Specialist, Medication Safety, Use & Policy
noyes@musc.edu

Dixie Runey, PharmD, BCPS
Clinical Specialist, Medication Safety, Use & Policy
stephed@musc.edu

Holly Griffin, PharmD
Manager, Pharmacy Information Solutions
Epic Clinical Team
griffinh@musc.edu